文献速递临床试验与 GCP真实世界研究与卫生经济

Maxm Skate下肢康复设备用于全膝关节置换术后的安全性、疗效与成本效果:随机对照试验研究方案

The safety, efficacy and cost-effectiveness of the Maxm Skate, a lower limb rehabilitation device for use following total knee arthroplasty: study protocol for a randomised controlled trial.
PubMed 文献 · Trials · 2019-01-10

本研究为单盲随机对照试验,计划纳入116例初次全膝关节置换术(TKA)患者,随机分入Maxm Skate家庭康复组或标准康复组,比较术后3个月膝关节活动度(主要结局)及患者报告结局、功能评估和成本效果(次要结局),随访至术后12个月。

要点

  • Maxm Skate为便携式家庭下肢康复设备,联合iOS应用与传感器指导训练。
  • 主要结局为术后3个月膝关节活动度,样本量按检测10°差异、90%把握度计算。
  • 次要结局包括患者报告结局、功能评估与经济学评价,随访至12个月。

核心结论

  • 该试验将首次比较Maxm Skate家庭康复方案与标准康复在初次TKA后的安全性、疗效与成本效果。

研究设计与样本

  • 样本量按术后3个月组间活动度差异10°、组内标准差16°、5%失访、90%把握度(α=0.05)估算。
  • 盲法物理治疗师在术前及术后2、4、6、12、26、52周评估功能结局,术后第2天由另一非盲物理治疗师进行有限评估。

关键数值与推荐

  • 主要结局为术后3个月膝关节活动度。
  • 次要结局包括患者报告结局、成本与功能评估,在术后多个时间点收集至12个月。
  • 功能评估包括膝关节活动度、疼痛、等长膝肌力、平衡及膝/大腿周径。
  • 临床结局指标在术前及术后6、12、52周实施。
  • 从知情同意至术后12个月进行不良事件筛查。

临床怎么用

  • 若证实有效且经济,Maxm Skate家庭康复方案可为TKA术后提供资源节约型的替代康复选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Physical rehabilitation is required to enhance functional outcomes and overall recovery following total knee arthroplasty (TKA). However, there are no universally accepted clinical guidelines available to consistently structure rehabilitation for TKA patients. A common method is rehabilitation provided in an outpatient setting, on a one-to-one treatment basis. This method is resource-intensive and outcomes must be compared to less costly alternatives such as home-based rehabilitation. The current study will analyse a novel home-based rehabilitation program. The Maxm skate is a portable, lower-limb, postoperative, rehabilitation exercise device for individual use in a hospital or home-based setting. This study was developed to compare the safety, efficacy and cost-effectiveness of the Maxm Skate rehabilitation program to standard rehabilitative care following TKA. The primary outcome is the range of motion (ROM) achieved by patients who received the Maxm Skate program compared to standard care at three months post TKA. Secondary outcomes include patient-reported outcomes, costs and functional evaluations which will be collected at multiple time-points up to 12 months after TKA. METHODS: This is a single-blinded, randomised controlled trial (RCT) in which 116 eligible participants consented for primary TKA will be randomly allocated to receive either the Maxm Skate rehabilitation program or standard rehabilitative care. Fifty-eight participants per group will provide 90% power (α = 0.05) to detect 10° of difference in ROM between groups at three months after TKA, assuming a within-group standard deviation of 16° and allowing for 5% loss to follow-up. Participants randomised to the Maxm Skate group will use the skate device and accompanying iOS App and sensors to complete rehabilitation exercises, as outlined in the Maxm Skate Rehabilitation Guide. Outcomes will be compared to those receiving standard rehabilitative care. A blinded physiotherapist will evaluate functional outcomes preoperatively and at 2, 4, 6, 12, 26 and 52 weeks after TKA. The functional assessment will include measures of knee ROM, pain, isometric knee strength, balance and knee/thigh circumference. Limited measures will also be assessed at day 2 postoperatively by an alternate, unblinded physiotherapist. Clinical outcome measures will be administered preoperatively and at 6, 12 and 52 weeks postoperatively. An economic evaluation will be conducted and participants will be screened for adverse event occurrences from the time of consent to 12 months postoperatively. DISCUSSION: This RCT will be the first to investigate the safety, efficacy and cost-effectiveness of the home-based Maxm Skate Rehabilitation program, in comparison to standard rehabilitative care following primary TKA. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12616001081404p . Registered on 11 August 2016.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Liptak MG, Theodoulou A, Kaambwa B, et al. The safety, efficacy and cost-effectiveness of the Maxm Skate, a lower limb rehabilitation device for use following total knee arthroplasty: study protocol for a randomised controlled trial. Trials. 2019. PMID: 30630494. doi:10.1186/s13063-018-3102-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。